UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 13, 2026
Accession Number:
0001104659-26-057914
Submission Type:
POS AM
CIK:
0001346830
Company Name:
Tvardi Therapeutics, Inc.
File Number:
333-287675